Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.05M Hold
13,941
1.41% 16
2026
Q1
$4.91M Sell
13,941
-496
-3% -$177K 1.56% 12
2025
Q4
$4.73M Hold
14,437
1.29% 14
2025
Q3
$4.07M Sell
14,437
-375
-3% -$109K 1.01% 16
2025
Q2
$4.14M Hold
14,812
0.82% 14
2025
Q1
$4.61M Hold
14,812
0.9% 13
2024
Q4
$3.86M Hold
14,812
0.75% 16
2024
Q3
$4.77M Hold
14,812
0.92% 14
2024
Q2
$4.63M Hold
14,812
0.85% 13
2024
Q1
$4.21M Sell
14,812
-2
-0% -$585 0.79% 14
2023
Q4
$4.27M Buy
14,814
+2
+0% +$545 0.91% 14
2023
Q3
$3.98M Sell
14,812
-275
-2% -$68.6K 0.84% 13
2023
Q2
$3.35M Hold
15,087
0.73% 14
2023
Q1
$3.65M Buy
+15,087
New +$3.7M 0.85% 12

Other funds holding AMGN

Sentry LLC's AMGN Position: Q2 2026 in Review

Sentry LLC held its Amgen (AMGN) position steady in Q2 2026 at 13,941 shares worth $5.05M. The position accounts for 1.41% of the portfolio, ranked #16.

Sentry LLC first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sentry LLC held 13,941 shares of Amgen worth $5.05M as of Q2 2026.
  • Sentry LLC left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 1.41% of Sentry LLC's portfolio in Q2 2026, its #16 holding.
  • Sentry LLC first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sentry LLC's 13F filing for Q2 2026, filed 14 Aug 2026.